Shopping Cart 0
Cart Subtotal
USD 0

Biotest AG (BIO) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Biotest AG (BIO)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Biotest AG (Biotest) provides pharmaceutical and biotherapeutic drugs. It develops, manufactures and distributes biological medicines through its value chain from preclinical and clinical development to sales. Its main products comprise clotting factors, immunoglobulins, albumin and monoclonal antibodies in clinical development. The company specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest distributes its products through local marketing partners and distributors in Europe, North America, South America, Asia, the Middle East and Africa. It has subsidiaries and sales companies in Austria, Switzerland, France, Great Britain, Italy, Hungary, Spain and in Brazil. Biotest is headquartered in Dreieich, Hessen, Germany.

Biotest AG Key Recent Developments

Jun 20,2018: Biotest opens third plasma collection centre in Czech Republic

Mar 22,2018: Biotest reaches 2017 profit guidance

Jan 24,2018: Biotest opens second plasma collection center in the Czech Republic

Nov 14,2017: Biotest generates revenues of EUR 377.8 million in the first nine months of 2017

Nov 06,2017: Biotest opens eighth plasma collection centre in Hungary

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Biotest AG-Key Facts 6

Biotest AG-Key Employees 7

Biotest AG-Key Employee Biographies 8

Biotest AG-Key Operational Employees 9

Biotest AG-Major Products and Services 10

Biotest AG-History 12

Biotest AG-Company Statement 15

Biotest AG-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Section 2-Company Analysis 18

Company Overview 18

Biotest AG-Business Description 19

Business Segment: Other Segments 19

Overview 19

Performance 19

Business Segment: Plasma & Services 19

Overview 19

Performance 19

Business Segment: Therapy 19

Overview 19

Performance 19

Geographical Segment: Germany 20

Performance 20

Geographical Segment: Middle East and Africa 20

Performance 20

Geographical Segment: Other Asia and Pacific 20

Performance 20

Geographical Segment: Rest of Americas (without USA) 20

Performance 20

Geographical Segment: Rest of Europe 20

Performance 20

R&D Overview 20

Biotest AG-Corporate Strategy 21

Biotest AG-SWOT Analysis 22

SWOT Analysis-Overview 22

Biotest AG-Strengths 22

Biotest AG-Weaknesses 23

Biotest AG-Opportunities 24

Biotest AG-Threats 25

Biotest AG-Key Competitors 26

Section 3-Company Financial Ratios 27

Financial Ratios-Capital Market Ratios 27

Financial Ratios-Annual Ratios 28

Performance Chart 31

Financial Performance 31

Financial Ratios-Interim Ratios 32

Financial Ratios-Ratio Charts 33

Section 4-Company's Lifesciences Financial Deals and Alliances 34

Biotest AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34

Biotest AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 35

Biotest AG, Recent Deals Summary 36

Section 5-Company's Recent Developments 37

Jun 20, 2018: Biotest opens third plasma collection centre in Czech Republic 37

Jun 20, 2018: Biotest opens third plasma collection centre in Czech Republic 38

Mar 22, 2018: Biotest reaches 2017 profit guidance 39

Jan 24, 2018: Biotest opens second plasma collection center in the Czech Republic 40

Jan 24, 2018: Biotest opens second plasma collection center in the Czech Republic 41

Nov 14, 2017: Biotest generates revenues of EUR 377.8 million in the first nine months of 2017 42

Nov 06, 2017: Biotest opens eighth plasma collection centre in Hungary 43

Oct 11, 2017: Biotest strengthens its position in the German haemophilia market with the introduction of new patient support services 44

May 16, 2017: Biotest opens seventh plasma collection center in Hungary 45

May 16, 2017: Biotest opens seventh plasma collection center in Hungary 46

Section 6-Appendix 47

Methodology 47

Ratio Definitions 47

About GlobalData 51

Contact Us 51

Disclaimer 51


List Of Figure

List of Figures

Biotest AG, Performance Chart (2013-2017) 31

Biotest AG, Ratio Charts 33

Biotest AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34

Biotest AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 35


List Of Table

List of Tables

Biotest AG, Key Facts 6

Biotest AG, Key Employees 7

Biotest AG, Key Employee Biographies 8

Biotest AG, Key Operational Employees 9

Biotest AG, Major Products and Services 10

Biotest AG, History 12

Biotest AG, Other Locations 16

Biotest AG, Subsidiaries 17

Biotest AG, Key Competitors 26

Biotest AG, Ratios based on current share price 27

Biotest AG, Annual Ratios 28

Biotest AG, Annual Ratios (Cont...1) 29

Biotest AG, Annual Ratios (Cont...2) 30

Biotest AG, Interim Ratios 32

Biotest AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34

Biotest AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 35

Biotest AG, Recent Deals Summary 36

Currency Codes 47

Capital Market Ratios 47

Equity Ratios 48

Profitability Ratios 48

Cost Ratios 49

Liquidity Ratios 49

Leverage Ratios 50

Efficiency Ratios 50

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Biotest AG, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Viramed Biotech AG

Medivir AB

Halozyme Therapeutics Inc

Grifols SA

Celltrion Inc

Biotest AG (BIO)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Biotest AG (Biotest) provides pharmaceutical and biotherapeutic drugs. It develops, manufactures and distributes biological medicines through its value chain from preclinical and clinical development to sales. Its main products comprise clotting factors, immunoglobulins, albumin and monoclonal antibodies in clinical development. The company specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest distributes its products through local marketing partners and distributors in Europe, North America, South America, Asia, the Middle East and Africa. It has subsidiaries and sales companies in Austria, Switzerland, France, Great Britain, Italy, Hungary, Spain and in Brazil. Biotest is headquartered in Dreieich, Hessen, Germany.

Biotest AG Key Recent Developments

Jun 20,2018: Biotest opens third plasma collection centre in Czech Republic

Mar 22,2018: Biotest reaches 2017 profit guidance

Jan 24,2018: Biotest opens second plasma collection center in the Czech Republic

Nov 14,2017: Biotest generates revenues of EUR 377.8 million in the first nine months of 2017

Nov 06,2017: Biotest opens eighth plasma collection centre in Hungary

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Biotest AG-Key Facts 6

Biotest AG-Key Employees 7

Biotest AG-Key Employee Biographies 8

Biotest AG-Key Operational Employees 9

Biotest AG-Major Products and Services 10

Biotest AG-History 12

Biotest AG-Company Statement 15

Biotest AG-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Section 2-Company Analysis 18

Company Overview 18

Biotest AG-Business Description 19

Business Segment: Other Segments 19

Overview 19

Performance 19

Business Segment: Plasma & Services 19

Overview 19

Performance 19

Business Segment: Therapy 19

Overview 19

Performance 19

Geographical Segment: Germany 20

Performance 20

Geographical Segment: Middle East and Africa 20

Performance 20

Geographical Segment: Other Asia and Pacific 20

Performance 20

Geographical Segment: Rest of Americas (without USA) 20

Performance 20

Geographical Segment: Rest of Europe 20

Performance 20

R&D Overview 20

Biotest AG-Corporate Strategy 21

Biotest AG-SWOT Analysis 22

SWOT Analysis-Overview 22

Biotest AG-Strengths 22

Biotest AG-Weaknesses 23

Biotest AG-Opportunities 24

Biotest AG-Threats 25

Biotest AG-Key Competitors 26

Section 3-Company Financial Ratios 27

Financial Ratios-Capital Market Ratios 27

Financial Ratios-Annual Ratios 28

Performance Chart 31

Financial Performance 31

Financial Ratios-Interim Ratios 32

Financial Ratios-Ratio Charts 33

Section 4-Company's Lifesciences Financial Deals and Alliances 34

Biotest AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34

Biotest AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 35

Biotest AG, Recent Deals Summary 36

Section 5-Company's Recent Developments 37

Jun 20, 2018: Biotest opens third plasma collection centre in Czech Republic 37

Jun 20, 2018: Biotest opens third plasma collection centre in Czech Republic 38

Mar 22, 2018: Biotest reaches 2017 profit guidance 39

Jan 24, 2018: Biotest opens second plasma collection center in the Czech Republic 40

Jan 24, 2018: Biotest opens second plasma collection center in the Czech Republic 41

Nov 14, 2017: Biotest generates revenues of EUR 377.8 million in the first nine months of 2017 42

Nov 06, 2017: Biotest opens eighth plasma collection centre in Hungary 43

Oct 11, 2017: Biotest strengthens its position in the German haemophilia market with the introduction of new patient support services 44

May 16, 2017: Biotest opens seventh plasma collection center in Hungary 45

May 16, 2017: Biotest opens seventh plasma collection center in Hungary 46

Section 6-Appendix 47

Methodology 47

Ratio Definitions 47

About GlobalData 51

Contact Us 51

Disclaimer 51


List Of Figure

List of Figures

Biotest AG, Performance Chart (2013-2017) 31

Biotest AG, Ratio Charts 33

Biotest AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34

Biotest AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 35


List Of Table

List of Tables

Biotest AG, Key Facts 6

Biotest AG, Key Employees 7

Biotest AG, Key Employee Biographies 8

Biotest AG, Key Operational Employees 9

Biotest AG, Major Products and Services 10

Biotest AG, History 12

Biotest AG, Other Locations 16

Biotest AG, Subsidiaries 17

Biotest AG, Key Competitors 26

Biotest AG, Ratios based on current share price 27

Biotest AG, Annual Ratios 28

Biotest AG, Annual Ratios (Cont...1) 29

Biotest AG, Annual Ratios (Cont...2) 30

Biotest AG, Interim Ratios 32

Biotest AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34

Biotest AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 35

Biotest AG, Recent Deals Summary 36

Currency Codes 47

Capital Market Ratios 47

Equity Ratios 48

Profitability Ratios 48

Cost Ratios 49

Liquidity Ratios 49

Leverage Ratios 50

Efficiency Ratios 50

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Biotest AG, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Viramed Biotech AG

Medivir AB

Halozyme Therapeutics Inc

Grifols SA

Celltrion Inc